Menu Search
Equities

Sri Trang Gloves (Thailand) PCL

STG:SES

Sri Trang Gloves (Thailand) PCL

Actions
Health CareMedical Equipment and Services
  • Price (SGD)0.50
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change+117.39%
  • Beta0.0370
Data delayed at least 10 minutes, as of Sep 06 2024 09:54 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sri Trang Gloves (Thailand) Public Company Limited is a glove manufacturer and fully integrated rubber company. It is engaged in the manufacturing of examinations and industrial gloves. It manufactures and distributes rubber gloves for medical and non-medical uses in other industries. Its products are Natural Rubber Powdered (NRPD), Natural Rubber Powdered-Free (NRPF), and Nitrile Butadiene Rubber (NBR) gloves, which are distributed in more than 170 countries worldwide. It offers a range of natural latex and nitrile examination gloves and general-purpose disposable gloves, both powdered and powder-free, catering to a variety of applications, including healthcare and medical, food processing, food handling, manufacturing and operations. NRPD are natural rubber gloves that are coated with powder on the inside for donning comfort. NRPF is an alternative product developed using technology to coat the contact surfaces inside rubber gloves to provide ease in wearing without cornstarch.

  • Revenue in THB (TTM)21.83bn
  • Net income in THB530.34m
  • Incorporated2019
  • Employees9.40k
  • Location
    Sri Trang Gloves (Thailand) PCL17th Floor, Park VentureEcoplex Unit 1701, 1707-1712No. 57 Wireless Road, Lumpini, PathumwanBANGKOK 10330ThailandTHA
  • Phone+66 22074500
  • Fax+66 21082241
  • Websitehttps://www.sritranggloves.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.